CHANDIGARH, Oct. 8 -- The Haryana Food and Drugs Administration (FDA) on Tuesday issued another "public alert" regarding two cough syrups---Respifresh TR and Relife---manufactured by two different pharmaceutical companies in Gujarat, after a toxic chemical, diethylene glycol (DEG) was found above permissible limits.

The syrups have been declared adulterated and not of standard quality.

In a "most urgent" letter to all senior drugs control officers (SDCOs) and all drugs control officers (DCOs), Haryana's state drugs controller Lalit Goel has stated that an official communication was received from the FDA of Madhya Pradesh and Gujarat in this connection following the drug formulations in question were found containing DEF impurity.

The a...